These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 378578)

  • 1. Clinical and experimental evaluation of cefoxitin therapy.
    Webb D; Thadepalli H; Bach V; Roy I
    Chemotherapy; 1979; 25(4):233-42. PubMed ID: 378578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cefoxitin sodium therapy in anaerobic infections.
    Thadepalli H; Webb D; Roy I; Bach V
    J Antimicrob Chemother; 1978 Jul; 4(B):203-8. PubMed ID: 357387
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with cefoxitin sodium.
    Ribner BS; Freimer EH; Billiard BS
    J Antimicrob Chemother; 1978 Jul; 4(B):209-10. PubMed ID: 357388
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of a clinical trial of cefoxitin, a new cephamycin antibiotic.
    McCloskey RV
    Antimicrob Agents Chemother; 1977 Nov; 12(5):636-41. PubMed ID: 335968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cefoxitin, new cephalosporin-like antibiotic, in the treatment of aerobic and anaerobic infections.
    Nair SR; Cherubin CE
    Antimicrob Agents Chemother; 1978 Dec; 14(6):866-75. PubMed ID: 742874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoxitin therapy for bacterial endocarditis.
    Webb D; Thadepalli H; Bach V
    Rev Infect Dis; 1979; 1(1):170-4. PubMed ID: 318219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of skin, soft tissue, and bone infections with cefoxitin sodium.
    Perkins RL; Slama TG; Fass RJ; Prior RB; Plouffe JF; Warner JF; File TM
    Rev Infect Dis; 1979; 1(1):165-9. PubMed ID: 318218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical considerations in skin and soft-tissue infections and osteomyelitis treated with cefoxitin sodium.
    Perkins RL
    J Antimicrob Chemother; 1978 Jul; 4(B):183-7. PubMed ID: 690021
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fundamental and clinica evaluation of cefoxitin in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Ookura K; Kuroki S; Murakami M; Tomizawa T; Kikawa Y; Kasei M; Hayashi R
    Jpn J Antibiot; 1981 Mar; 34(3):318-32. PubMed ID: 7289025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythromycin for anaerobic pleuropulmonary and soft-tissue infections.
    Goldstein EJ; Lewis RP; Sutter VL; Finegold SM
    JAMA; 1979 Aug; 242(5):435-8. PubMed ID: 448959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anaerobic infections with lincomycin and clindamycin.
    Bartlett JG; Sutter VL; Finegold SM
    N Engl J Med; 1972 Nov; 287(20):1006-10. PubMed ID: 4346707
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR
    Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of infections due to anaerobic bacteria.
    Del Bene VE; Farrar WE
    Semin Drug Treat; 1972; 2(3):295-312. PubMed ID: 4617925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients].
    Kaseki S; Mano T; Tomoda Y; Kazato S; Asai Y; Sahara K; Manba S; Maruyama T; Kasugai M; Higashide K; Sekiya H; Mizutani S; Watanabe K; Ueno K
    Jpn J Antibiot; 1983 Mar; 36(3):509-21. PubMed ID: 6876361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticarcillin disodium in anaerobic infections.
    Webb D; Thadepalli H; Roy I; Bach VT
    Arch Intern Med; 1978 Nov; 138(11):1618-20. PubMed ID: 718311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical findings of cefoxitin in the treatment of obstetric and gynecological infections (author's transl)].
    Hayasaki M; Iwasa SU; Noda K; Yamada Y; Ito K; Iida M; Chin C
    Jpn J Antibiot; 1982 Jan; 35(1):189-201. PubMed ID: 7069930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefoxitin: clinical evaluation in thirty-eight patients.
    Heseltine PN; Busch DF; Meyer RD; Finegold SM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):427-34. PubMed ID: 855997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.